Research shows tests could detect Alzheimer’s earlier

LEXINGTON, Ky. (ABC36 NEWS NOW) – Alzheimer’s is a disease that affects nearly 81,000 Kentuckians and their families.

But a new FDA approved drug and blood tests could help with early detection.

There are quite a few myths when it comes to Alzheimer’s. Such as memory loss is a normal part of aging and Alzheimer’s only affects older people.

But the disease is cause by the protein amyloid, which degenerates the neurons in the brain.

“We think it takes up to 20 years before patients come with symptoms, they may have the proteins accumulating,” said Dr. Fred Odago, a neurologist at CHI Saint Joseph Medical Group. “So the next area, I think, is going to be prevention of Alzheimer’s. I think it’s all very exciting.”

On Thursday, the Alzheimer’s Association of Greater Kentucky and Southern Indiana announced the release of a new drug, Kisunla, meant to target the protein.

“These new drugs actually target the disease,” said Dr. Odago. “They’re called disease modifying therapy, because they target this amyloid protein and actually clear this from the system.”

The Alzheimer’s Association also hopeful about research into early diagnosis of Alzheimer’s through a blood test.

“It’s more accurate up to 90 percent and then also, it offers not only accuracy but more options for care and treatment,” said Director of Programs Erin Gillespie. “And it’s not as invasive as what we have today.”

Right now, doctors say the only way to be diagnosed is by getting a spinal tap or a pet scan.

Officials at the announcement say the next step is prevention and then eventually a cure.